Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.
Archived – Soloslim
- Starting date:
- August 18, 2008
- Posting date:
- August 18, 2008
- Type of communication:
- Foreign Product Alert (FPA)
- Natural health products
- Source of recall:
- Health Canada
- Important Safety Information, Undeclared Substance
- General Public
- Identification number:
These products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.
Source of alert
Hong Kong Department of Health
Manufacturer / Place of origin
EZVille, Ltd., Long Island, NY, U.S.A.
Soloslim is promoted as an "all natural" product used for weight loss.
Reason for warning
The Hong Kong Department of Health warned against the use of Soloslim because it was found to contain an undeclared compound similar in structure to sibutramine (N-bisdesmethyl-sibutramine). Sibutramine is a prescription drug used in the treatment of obesity.
Soloslim also contains L-carnitine salt. L-carnitine is a prescription drug used in the treatment of carnitine deficiency, which may occur in patients with some genetic diseases, serious liver or kidney disease or with use of certain medications (e.g., valproate).
Both sibutramine and L-carnitine should only be used under the supervision of a health care professional.
Soloslim also contains synephrine. Weight loss products containing synephrine are not authorized for sale in Canada.
Possible side effects
- Use of sibutramine may cause headaches, increased heart rate and blood pressure, chest pain and stroke.
- Side effects associated with L-carnitine include nausea, vomiting, abdominal cramps, diarrhea and seizures.
- Synephrine may cause cardiovascular adverse effects that could lead to stroke, heart attack and/or death.
What you should do
Canadians who have this product are advised not to use it, and should consult with a health care professional if they have concerns about their health related to the use of this product.
Health Canada advises Canadians to contact the Health Products and Food Branch Inspectorate at 1-800-267-9675 if they find the product listed above in the Canadian marketplace.
Drugs and natural health products that are authorized for sale in Canada will have either an eight-digit Drug Identification Number (DIN), a Natural Product Number (NPN) or a Homeopathic Medicine Number (DIN-HM) on the label. These numbers indicate that the products have been assessed by Health Canada for safety, effectiveness and quality.
As of the date of this posting, no adverse reactions suspected to be associated with the use of this product have been reported in Canada.
Report a health or safety concern
- Call toll-free at 1-866-234-2345.
- Visit Health Canada's Web page on Adverse Reaction Reporting for information on how to report online, by mail or by fax.
Select thumbnail to enlarge - opens in a new window
- Date modified: